AI assistant
Sending…
Onconetix, Inc. — Director's Dealing 2022
Feb 23, 2022
35411_dirs_2022-02-23_bb224224-10af-4354-9afb-b410de178ccd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Blue Water Vaccines Inc. (BWV)
CIK: 0001782107
Period of Report: 2022-02-23
Reporting Person: SAPIRSTEIN JAMES (Director)
More from Onconetix, Inc.
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Mar 30
Regulatory Filings
2026
Mar 18
Regulatory Filings
2026
Feb 12
Regulatory Filings
2026
Feb 12
Regulatory Filings
2026
Feb 9